Singapore markets closed

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
64.79+0.20 (+0.31%)
At close: 04:00PM EST
64.81 +0.02 (+0.03%)
After hours: 07:50PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 199.63B
Enterprise value 223.09B
Trailing P/E 34.28
Forward P/E 15.53
PEG Ratio (5 yr expected) 0.50
Price/sales (ttm)4.49
Price/book (mrq)5.40
Enterprise value/revenue 4.96
Enterprise value/EBITDA 16.38

Trading information

Stock price history

Beta (5Y monthly) 0.19
52-week change 3-5.31%
S&P500 52-week change 314.90%
52-week high 376.56
52-week low 361.73
50-day moving average 365.21
200-day moving average 368.90

Share statistics

Avg vol (3-month) 35.49M
Avg vol (10-day) 35.23M
Shares outstanding 53.1B
Implied shares outstanding 63.11B
Float 81.54B
% held by insiders 10.01%
% held by institutions 117.16%
Shares short (14 Nov 2023) 49.01M
Short ratio (14 Nov 2023) 41.11
Short % of float (14 Nov 2023) 4N/A
Short % of shares outstanding (14 Nov 2023) 40.26%
Shares short (prior month 12 Oct 2023) 45.86M

Dividends & splits

Forward annual dividend rate 41.45
Forward annual dividend yield 42.24%
Trailing annual dividend rate 32.90
Trailing annual dividend yield 34.49%
5-year average dividend yield 42.62
Payout ratio 476.72%
Dividend date 310 Sept 2023
Ex-dividend date 409 Aug 2023
Last split factor 22:1
Last split date 326 Jul 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin 13.10%
Operating margin (ttm)22.04%

Management effectiveness

Return on assets (ttm)9.23%
Return on equity (ttm)16.32%

Income statement

Revenue (ttm)44.99B
Revenue per share (ttm)2.41
Quarterly revenue growth (yoy)4.60%
Gross profit (ttm)35.73B
Net income avi to common (ttm)5.9B
Diluted EPS (ttm)1.89
Quarterly earnings growth (yoy)-16.20%

Balance sheet

Total cash (mrq)5.11B
Total cash per share (mrq)3.3
Total debt (mrq)29.55B
Total debt/equity (mrq)79.40%
Current ratio (mrq)0.79
Book value per share (mrq)24.01

Cash flow statement

Operating cash flow (ttm)10.36B
Levered free cash flow (ttm)12.67B